# OnCo record atempt (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/atempt/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "atempt", "NCT01853748" ;
  schema:name "ATEMPT"@en ;
  schema:description "ATEMPT tested whether a year of the antibody-drug conjugate T-DM1 could replace chemotherapy plus trastuzumab for the smallest HER2-positive breast cancers; almost no one relapsed on T-DM1, but it was not less toxic overall, so it is an alternative rather than a replacement."@en ;
  schema:url <https://onco.cc/trials/atempt/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT01853748> ;
  onco:status "mixed" ;
  onco:tag "subtype-trials" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/her2-positive-early-breast-cancer/>, <https://onco.cc/cancers/breast-her2-positive/>, <https://onco.cc/cancers/breast-cancer/> ;
  onco:drugs <https://onco.cc/drugs/trastuzumab-emtansine/>, <https://onco.cc/drugs/paclitaxel/>, <https://onco.cc/drugs/trastuzumab/> ;
  onco:companies <https://onco.cc/companies/roche-genentech/> ;
  onco:people <https://onco.cc/people/sara-tolaney/> .